ESSENTIAL information about managing Covid-19 in adults and children has now been published in a single NICE guideline.
The guideline covers the management of clinically or lab-diagnosed Covid-19 for children, young people and adults across all care settings. It lists the key symptoms of Covid-19 for identifying patients with severe illness, including confusion, reduced oxygen levels, and shortness of breath. New recommendations on therapeutics are included and the guideline will be updated as new evidence emerges.
Development of the guideline was undertaken in the MAGICapp platform, a global system that promotes evidence sharing from different guideline creators, therefore increasing the speed at which guidance can be developed and updated.
Dr Paul Chrisp, Director of the Centre for Guidelines at NICE, said: "This new living guideline is the latest development in our ongoing response to the Covid-19 pandemic, and we hope its publication will support healthcare professionals caring for patients unwell with Covid-19.
"The pandemic has driven new collaborative and international ways of working, and by sharing high-quality evidence with our colleagues around the world we have been able to develop this guidance more quickly. By keeping abreast with the latest evidence, we hope to identify which guidance needs updating more efficiently."